Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These 4 Stocks Have Started the Week Off on the Right Foot

Page 1 of 2

The markets have continued to tumble in the second week of 2016, with all major U.S stock indexes now down today after a mild rally earlier in the day. Despite the general decline in equities, a few stocks are bucking the 2016 trend and trading up today. Among them we can count Nevro Corp (NYSE:NVRO), Community Health Systems (NYSE:CYH), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), and Tenet Healthcare Corp (NYSE:THC), and we’ll take a look into what’s driving the surges in these company’s stocks and what the hedge funds in our database think about these companies.

In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, Insider Monkey looks at only the aristocrats of this group, around 730 funds. Contrary to popular belief, Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge, not because they are not good at picking stocks on the long side of their portfolios. Hedge funds did in fact manage to outperform the market on the long side of their portfolios (see the details here).

Let’s commence with Nevro Corp (NYSE:NVRO), a small-cap medical device company that hit a 52-week high on Monday, before settling around $69.20, up by almost 7%. The surge was triggered by the announcement of the company’s preliminary fourth quarter financial results. Management now expects revenue in the range of $32.6 million-to-$33.1 million, up from $9.7 million in the same quarter of last year, and ahead of the Street’s expectations.

Follow Nevro Corp (NYSE:NVRO)
Trade (NYSE:NVRO) Now!

Nevro Corp (NYSE:NVRO) seems to be gaining in popularity among the hedge funds in our database. As of the end of the third quarter of 2015, 21 of them held long stakes in the company, up by more than 10% quarter-over-quarter. A fund that seemed particularly bullish was Kevin Kotler’s Broadfin Capital, which almost quadrupled its holding over the third quarter, lifting it to more than 1.6 million shares worth roughly $74.5 million.

Next up is Community Health Systems (NYSE:CYH), which had gained nearly 10% today on high trading volume before giving back much of those gains later in the day. Although there was apparently no specific catalyst on Monday in terms of news, the small-cap hospital company announced last Friday that it was expecting to complete the spinoff of its Quorum Health Resources segment by June, rather than in the first quarter of 2016, as was originally projected.

Follow Community Health Systems Inc (NYSE:CYH)
Trade (NYSE:CYH) Now!

Unlike Nevro Corp (NYSE:NVRO), Community Health Systems (NYSE:CYH) saw hedge fund interest decline over the latest reported quarter. Among the hedge funds that we track, 59 disclosed long positions in the company; while this figure is quite high, it is still lower than the 61 funds betting on the firm at the end of the second quarter of 2015. Interestingly, however, these 59 investment firms own more than 23% of Community Health Systems’ total shares, with Larry Robbins’ Glenview Capital holding over 10% (or about 12.09 million shares) of that total outstanding stock.

On the next page we will take a look at why AMAG Pharmaceuticals and Tenet Healthcare Corp are surging in afternoon trading.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!